NYSE · Financial Statements

MetLife, Inc. (MET) Financial Statements

$98.82 NYSE: MET Market Cap $62.80B

MetLife, Inc. most recently reported annual revenue of $77.1B, net profit of $3.4B. Revenue grew at an average annual rate of 2.6% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

MetLife, Inc.: Revenue rose from $60.5B in 2016 to $77.1B in 2025, a change of +27.4% over 9 years; net profit was positive in all 10 reported years; operating margin moved from 7.1% to 6.0%, a shift of -1.0 percentage points; the most recent year shows net profit of $3.4B.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$60.5B$62.3B$67.9B$69.6B$67.9B$63.4B$68.0B$67.7B$69.9B$77.1B
Operating Expenses$56.2B$58.8B$61.6B$62.8B$61.0B$54.8B$61.6B$65.5B$64.3B$72.4B
Operating Profit$4.3B$3.5B$6.3B$6.8B$6.9B$8.5B$6.4B$2.2B$5.6B$4.7B
Operating Margin7.1%5.7%9.3%9.8%10.2%13.4%9.4%3.2%8.0%6.0%
Other Income$0$0$0$0$0$0$0$0$0$0
Interest$1.2B$1.1B$1.1B$955.0M$913.0M$920.0M$938.0M$1.0B$1.0B$1.1B
Depreciation$652.0M$795.0M$628.0M$630.0M$619.0M$694.0M$673.0M$718.0M$714.0M$753.0M
Profit Before Tax$4.3B$3.5B$6.3B$6.8B$6.9B$8.5B$6.4B$2.2B$5.6B$4.7B
Tax$16.2M$-41.6M$18.7M$13.0M$21.8M$19.3M$16.7M$25.9M$20.9M$27.0M
Net Profit$850.0M$4.0B$5.1B$5.9B$5.4B$6.9B$5.3B$1.6B$4.4B$3.4B
EPS$0.67$3.74$4.91$6.06$5.68$7.65$6.30$1.81$5.94$4.80
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$15.9B$19.0B$15.9B$17.5B$18.3B$18.4B$18.3B$17.2B$16.9B$23.8B$19.1B$18.9B
Operating Expenses$15.3B$18.1B$14.9B$16.3B$16.3B$17.1B$16.9B$16.2B$15.7B$22.7B$17.6B$17.8B
Operating Profit$534.0M$941.0M$1.0B$1.2B$2.0B$1.4B$1.4B$980.0M$1.2B$1.1B$1.5B$1.0B
Operating Margin3.4%5.0%6.6%6.9%10.9%7.5%7.4%5.7%7.2%4.7%7.9%5.5%
Interest$265.0M$269.0M$264.0M$257.0M$257.0M$259.0M$258.0M$269.0M$271.0M$263.0M$265.0M$292.0M
Profit Before Tax$534.0M$941.0M$1.0B$1.2B$2.0B$1.4B$1.4B$980.0M$1.2B$1.1B$1.5B$1.0B
Tax$7.3M$34.8M$16.3M$20.7M$32.8M$7.7M$29.8M$25.0M$25.4M$26.9M$22.9M$24.7M
Net Profit$489.0M$607.0M$867.0M$946.0M$1.3B$1.3B$945.0M$729.0M$896.0M$809.0M$1.2B$736.0M
EPS$0.56$0.77$1.10$1.28$1.81$1.78$1.28$1.03$1.22$1.17$1.74$1.08

Over the 10 years reported for MetLife, Inc., borrowings increased from $19.9B in 2016 to $20.2B in 2025, cash stood at $22.0B in the latest year, shareholders' equity was $12.0M, current assets covered current liabilities 0.65 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$898.8B$719.9B$687.5B$740.5B$795.1B$759.7B$663.1B$687.6B$677.5B$745.2B
Current Assets$0$0$0$0$0$388.0B$335.5B$350.6B$143.0B$179.6B
Cash$12.7B$12.7B$15.8B$16.6B$19.8B$20.0B$20.2B$20.6B$20.1B$22.0B
Inventory$0$0$0$0$0$0$0$0$0$0
Receivables$15.5B$18.4B$19.6B$20.4B$17.9B$20.5B$22.2B$33.8B$34.3B$54.3B
Fixed Assets$0$0$0$0$0$0$1.9B$2.0B$1.9B$1.7B
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$603.1B$652.6B$625.1B$685.5B$741.3B$494.8B$428.0B$440.4B$435.4B$466.1B
Other Assets$9.2B$9.6B$9.4B$9.3B$10.1B$9.5B$9.3B$9.2B$8.9B$9.6B
Total Liabilities$831.1B$661.0B$634.6B$674.1B$720.3B$692.0B$632.9B$657.3B$649.8B$716.2B
Current Liabilities$0$0$0$0$0$263.2B$251.1B$257.6B$258.1B$276.1B
Borrowings$19.9B$19.3B$16.2B$16.9B$18.1B$17.4B$18.0B$18.8B$18.7B$20.2B
Other Liabilities$811.2B$641.7B$618.3B$657.2B$702.2B$674.5B$615.0B$638.5B$631.0B$696.1B
Equity$12.0M$12.0M$12.0M$12.0M$12.0M$12.0M$12.0M$12.0M$12.0M$12.0M
Reserves$67.5B$58.7B$52.7B$66.1B$74.6B$67.5B$29.9B$30.0B$27.4B$28.4B

For MetLife, Inc., operating cash flow was positive in 10 of 10 reported years; free cash flow in the latest year was $18.1B; free cash flow was positive in 10 of 10 years.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$14.7B$12.7B$9.5B$13.9B$11.5B$12.8B$11.4B$14.3B$15.1B$18.1B
Investing Cash Flow$-5.8B$-16.9B$-5.6B$-17.6B$-18.6B$-11.2B$-2.6B$-10.2B$-11.5B$-15.6B
Financing Cash Flow$-311.0M$1.3B$-348.0M$6.0B$9.8B$1.1B$-9.0B$-2.1B$-422.0M$2.4B
Net Cash Flow$-101.0M$50.0M$3.1B$777.0M$3.2B$252.0M$148.0M$444.0M$-571.0M$2.0B
Free Cash Flow$14.7B$12.7B$9.5B$13.9B$11.5B$12.8B$11.4B$14.3B$15.1B$18.1B

Valuation & Return Ratios

MetricValue
PEG Ratio-1.60
EV / EBITDA10.15
FCF Yield26.36%
Quick Ratio453.01
Interest Coverage4.46
Return 1Y33.54%
Return 3Y90.60%
Return 5Y80.00%

MetLife, Inc. (MET) financials — frequently asked questions

What is MetLife, Inc.'s annual revenue?

MetLife, Inc. (MET) reported annual revenue of $77.1B in its most recent fiscal year.

What is MetLife, Inc.'s net profit?

MetLife, Inc. (MET) reported net profit of $3.4B in its most recent fiscal year.

What is MET EV/EBITDA?

MetLife, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 10.15.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Financial Services StocksLow P/E Financial Services StocksHigh Net Margin Financial Services StocksDividend Financial Services StocksLow Debt Financial Services StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
MET Overview MET Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.